Impact of Sex Assigned At Birth and HIV Acquisition Route on Long-Acting Cabotegravir plus Rilpivirine Persistence: A Real-World Cohort Study.

Cossu, Maria Vittoria; Giacomelli, Andrea; Oreni, Letizia; Moschese, Davide; Carrozzo, Giorgia; Fusetti, Chiara; Gori, Andrea; Gervasoni, Cristina; Ridolfo, Anna Lisa

doi:10.1016/j.ijid.2026.109001

Impact of Sex Assigned At Birth and HIV Acquisition Route on Long-Acting Cabotegravir plus Rilpivirine Persistence: A Real-World Cohort Study.

2026-07-23, International Journal of Infectious Diseases (10.1016/j.ijid.2026.109001) (online)
Maria Vittoria Cossu, Andrea Giacomelli, Letizia Oreni, Davide Moschese, Giorgia Carrozzo, Chiara Fusetti, Andrea Gori, Cristina Gervasoni, and Anna Lisa Ridolfo (?)

Despite growing adoption of long-acting antiretroviral therapy, real-world data on sex-related differences in treatment persistence remain limited.

This article has not yet been included in any curations.

Comments

There are no comments on this article yet.

You need to login or register to comment.

BioSothis

Impact of Sex Assigned At Birth and HIV Acquisition Route on Long-Acting Cabotegravir plus Rilpivirine Persistence: A Real-World Cohort Study.